The Management of Glaucoma in the Indigent Clinic Patient*
- 1 December 1961
- journal article
- Published by Elsevier in American Journal of Ophthalmology
- Vol. 52 (6) , 867-871
- https://doi.org/10.1016/0002-9394(61)90330-0
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Phospholine Iodide (217MI) and Demecarium Bromide (BC48) in the Management of Glaucoma* *From the Glaucoma Clinic, University Hospital. This study was supported by Dominion-Provincial Grant No. 607-9-160. Based on a paper read to the Canadian Ophthalmological Society, October, 1959. Phospholine Iodide was kindly supplied by Campbell Pharmaceutical Company, New York. Demecarium Bromide was kindly supplied by Merck, Sharp and Dohme Company, Montreal, Canada.American Journal of Ophthalmology, 1960
- The Clinical Evaluation of Echothiophate (Phospholine Iodide) in the Treatment of Glaucoma*American Journal of Ophthalmology, 1960
- Use of Echothiophate (Phospholine Iodide † ) in the Treatment of Glaucoma * : In the Coachella Valley of CaliforniaAmerican Journal of Ophthalmology, 1960
- Demecarium Bromide and Echothiophate Iodide in Chronic GlaucomaArchives of Ophthalmology (1950), 1960
- Echothiophate (Phospholine) Iodide (217-MI) in Treatment of GlaucomaA.M.A. Archives of Ophthalmology, 1959
- The Tonographic Effects of Echothiophate (Phospholine) Iodide*American Journal of Ophthalmology, 1959
- Use of a Thiophosphinyl Quaternary Compound (217-MI) in Treatment of GlaucomaArchives of Ophthalmology (1950), 1957